DSpace at RU >

Browsing by Author Welsing, P.M.J.

Full Text	Issue Date	Title	Author(s)
	2006	The functional variant of the inhibitory Fcgamma receptor IIb (CD32B) is associated with the rate of radiologic joint damage and dendritic cell function in rheumatoid arthritis.	Radstake, T.R.D.J.; Franke, B.; Wenink, M.H.; Nabbe, K.C.A.M.; Coenen, M.J.J., et al
	2006	Wordt reumatoide arthritis een mildere ziekte? Patienten met reumatoide arthritis gevolgd over 20 jaar.	Welsing, P.M.J.; Riel, P.L.C.M. van
	2006	An investigation of clinical studies suggests those with multiple objectives should have at least 90% power for each endpoint.	Borm, G.F.; Houben, R.; Welsing, P.M.J.; Zielhuis, G.A.
	2006	The initial validation of a Markov model for the economic evaluation of (new) treatments for rheumatoid arthritis.	Welsing, P.M.J.; Severens, J.L.; Hartman, M.; Gestel, A.M. van; Riel, P.L.C.M. van, et al
	2006	Minimal clinically important difference in radiological progression of joint damage. A definition based on patient perspective.	Welsing, P.M.J.; Borm, G.F.; Riel, P.L.C.M. van
	2006	Comment on the use of self-reporting instruments to assess patients with rheumatoid arthritis: the longitudinal association between the DAS28 and the VAS general health.	Kievit, W.; Welsing, P.M.J.; Adang, E.M.M.; Eijsbouts, A.M.M.; Krabbe, P.F.M., et al
	2005	Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.	Radstake, T.R.D.J.; Sweep, C.G.J.; Welsing, P.M.J.; Franke, B.; Vermeulen, S., et al
	2005	Quality of life and costs for different strategies for rheumatoid arthritis.	Welsing, P.M.J.; Kievit, W.; Laan, R.F.J.M.; Severens, J.L.
	2005	The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study.	Flendrie, M.; Creemers, M.C.W.; Welsing, P.M.J.; Riel, P.L.C.M. van
	2005	Cardiovascular risk factors in RA and their modulation during TNF-alpha blockade.	Popa, C.; Welsing, P.M.J.; Veerkamp, M.J.; Riel, P.L.C.M. van
	2005	Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis.	Welsing, P.M.J.; Fransen, J.; Riel, P.L.C.M. van
	2005	Interrelations between process and outcome measures over the course of rheumatoid arthritis	Welsing, P.M.J.
	2004	The Nijmegen inception cohort of early rheumatoid arthritis	Welsing, P.M.J.; Riel, P.L.C.M. van
	2004	The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome.	Radstake, T.R.D.J.; Franke, B.; Hanssen, S.L.J.; Netea, M.G.; Welsing, P.M.J., et al
	2004	The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis.	Welsing, P.M.J.; Landewe, R.B.; Riel, P.L.C.M. van; Boers, M.; Gestel, A.M. van, et al
	2004	Modeling the 5-year cost effectiveness of treatment strategies including tumor necrosis factor-blocking agents and leflunomide for treating rheumatoid arthritis in the Netherlands.	Welsing, P.M.J.; Severens, J.L.; Hartman, M.; Riel, P.L.C.M. van; Laan, R.F.J.M.